Iyasere Osasuyi, Brown Edwina A
Imperial College Renal and Transplant Centre, Hammersmith Hospital, London, UK.
Postgrad Med J. 2014 Jun;90(1064):340-7. doi: 10.1136/postgradmedj-2013-132251. Epub 2014 Mar 24.
The incidence of older patients with end stage renal disease is on the increase. This group of patients have multiple comorbidities and a high symptom burden. Dialysis can be life sustaining for such patients. But it is often at the expense of quality of life, which starts to decline early in the pathway of chronic kidney disease. Quality of life is also important to patients and is a major determinant in decisions regarding renal replacement. As a result, validated patient-reported outcome measures are increasingly used to assess quality of life in renal patients. Cognitive impairment, depression, malnutrition and function decline are non-renal determinants of quality of life and mortality. They are under-recognised in the renal population but are potentially treatable, if not preventable. This review article discusses aetio-pathogenesis, prevalence and impact of these four outcomes, advocating regular screening for early identification and management.
老年终末期肾病患者的发病率正在上升。这组患者有多种合并症且症状负担较重。透析可维持这类患者的生命。但这往往是以生活质量为代价的,生活质量在慢性肾病进程早期就开始下降。生活质量对患者也很重要,并且是肾替代治疗决策的主要决定因素。因此,经过验证的患者报告结局指标越来越多地用于评估肾病患者的生活质量。认知障碍、抑郁、营养不良和功能衰退是生活质量和死亡率的非肾脏决定因素。它们在肾病患者中未得到充分认识,但即使无法预防,也有可能进行治疗。这篇综述文章讨论了这四种结局的病因发病机制、患病率及影响,提倡进行定期筛查以便早期识别和管理。